glp 1 while trying to conceive GLP-1 weight-loss drugs pose hidden risks for young women Is Ozempic safe to take

Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses

The Liposomal Advantage To solve this problem, we utilize liposomal delivery

Recently they published and presented data on the combination of Taltz which is a monoclonal antibody that targets interleukin 17A(IL-17a) and tirzepatide for patients with psoriatic arthritis

Back to Journals Diabetes, Metabolic Syndrome and Obesity Volume 19 GLP-1 Agonists in Adolescent Obesity: A Narrative Review of Single, Dual, and Triple Agonists Authors Abid M, Sheikh KS, Ahmad MS, Jiang H Received 19 January 2026 Accepted for publication 17 March 2026 Published 12 June 2026 Volume 2026:19 566414 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Dr Donald McClain Mahroz Abid, 1 Khizer Sohail Sheikh, 1 Muhammad Shahbaz Ahmad, 2 Hongwei Jiang 1 1 Department of Metabolism and Endocrinology, Endocrine and Metabolic Disease Center, The First Affiliated Hospital and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, Peoples Republic of China